OGT and Intelliseq Launch NGS Reporting and Interpretation for All Myeloid Malignancy Panels
OGT and Intelliseq Launch NGS Reporting and Interpretation for All Myeloid Malignancy PanelsFuelled by cutting-edge clinical and genomic data, partnership provides intuitive and fully customisable reporting capabilities for all conditionsOxford, UK – 26 October 2023. OGT, A Sysmex Group Company and leading glo...
Source: pharmiweb.com